Global Atherectomy and Thrombectomy Devices Market 2012-2016

SKU ID :TNV-10282564 | Published Date: 19-Apr-2013 | No. of pages: 55
1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Research Methodology 5. Scope of the Report Market Overview Product Offerings 6. Market Landscape 6.1. Global Peripheral Vascular Devices Market Market Size and Forecast 6.2. Key Market Segmentation 6.3. Global Atherectomy Devices Market Market Size Market Forecast 6.4. Key Market Segmentation of Atherectomy Devices 6.5. Atherectomy Devices Market in the US Market Size and Forecast 6.6. Global Thrombectomy Devices Market Market Size Market Forecast 6.7. Key Market Segmentation of Thrombectomy Devices 6.8. Thrombectomy Devices Market in the US Market Size and Forecast 6.9. Five Force Analysis 7. Geographical Segmentation 8. Key Leading Countries USA Japan Germany 9. Rate of Incidence and Prevalence Diabetes Cancer AIDS 10. Vendor Landscape 11. Buying Criteria 12. Market Growth Drivers 13. Drivers and their Impact 14. Market Challenges 15. Impact of Drivers and Challenges 16. Market Trends 17. Key Vendor Analysis 17.1. Bayer AG 17.1.1. Business Overview 17.1.2. Business Segmentation 17.1.3. Key Information 17.1.4. SWOT Analysis 17.2. Boston Scientific Corp. 17.2.1. Business Overview 17.2.2. Business Segmentation 17.2.3. Key Information 17.2.4. SWOT Analysis 17.3. Covidien plc 17.3.1. Business Overview 17.3.2. Business Segmentation 17.3.3. Key Information 17.3.4. SWOT Analysis 17.4. Getinge AB 17.4.1. Business Overview 17.4.2. Business Segmentation 17.4.3. Key Information 17.4.4. SWOT Analysis 17.5. Vascular Solutions Inc. 17.5.1. Business Overview 17.5.2. Business Segmentation 17.5.3. Key Information 17.5.4. SWOT Analysis 18. Other Reports in this Series List of Exhibits: Exhibit 1: Global Peripheral Vascular Devices Market 2012–2016 (US$ billion) Exhibit 2: Global Peripheral Vascular Devices Market by Category Segmentation Exhibit 3: Global Atherectomy Devices Market 2012–2016 (US$ million) Exhibit 4: Category Segmentation of Atherectomy Devices Exhibit 5: Atherectomy Devices Market in the US 2012–2016 (US$ million) Exhibit 6: Global Thrombectomy Devices Market 2012–2016 (US$ million) Exhibit 7: Category Segmentation of Thrombectomy Devices Exhibit 8: Thrombectomy Devices Market in the US 2012–2016 (US$ million) Exhibit 9: Global Atherectomy Devices Market by Geographical Segmentation 2012 Exhibit 10: Global Thrombectomy Devices Market by Geographical Segmentation 2012 Exhibit 11: Global Atherectomy Devices Market by Vendor Segmentation 2012 Exhibit 12: Global Thrombectomy Devices Market by Vendor Segmentation 2012 Exhibit 13: Business Segmentation of Bayer AG Exhibit 13: Business Segmentation of Boston Scientific Corp. Exhibit 13: Business Segmentation of Covidien plc Exhibit 13: Business Segmentation of Getinge AB Exhibit 13: Business Segmentation of Vascular Solutions Inc.
Bayer AG, Boston Scientific Corp., Covidien plc, Getinge AB, Spectranetics Corp., Straub Medical AG, Vascular Solutions Inc. ,3M Co., American Heart Association Inc., Aerotel Medical Systems Ltd., Asian Heart Institute, Cook Medical Inc., ev3 Inc., Heartware International Ltd., Nihon Kohden Corp., Smith & Nephew plc, Sorin Group USA Inc., St. Jude Medical Inc., Terumo Medical Corp., Ventracor Ltd., Uscom Ltd.,Zoll Medical Corp.
  • PRICE
  • $2500
    $4000

Our Clients